Itamar Medical Ltd. Research and Development Expense
Itamar Medical Ltd. reported Research and Development Expense of $6.00 million for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-29.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2021-03-29
- Itamar Medical Ltd. research and development expense for the quarter ending 2020-12-31 was $1.94M, a 43.03% increase year-over-year.
- Itamar Medical Ltd. research and development expense for the quarter ending 2020-09-30 was $1.39M, a 26.48% increase year-over-year.
- Itamar Medical Ltd. research and development expense for the quarter ending 2019-12-31 was $1.35M.
- Itamar Medical Ltd. research and development expense for the quarter ending 2019-09-30 was $1.09M.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 9 month | Research And Development Expense 12 month |
|---|---|---|---|---|
| 2020-12-31 | $1.94M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-29 | $3.32M derived: sum of 2 quarters · filed 2021-03-29 | $6.00M 20-F · filed 2021-03-29 | |
| 2020-09-30 | $1.39M 6-K · filed 2020-11-17 | $4.06M 6-K · filed 2020-11-17 | ||
| 2019-12-31 | $1.35M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-29 | $2.45M derived: sum of 2 quarters · filed 2021-03-29 | $4.52M 20-F · filed 2021-03-29 | |
| 2019-09-30 | $1.09M 6-K · filed 2020-11-17 | $3.17M 6-K · filed 2020-11-17 | ||
| 2018-12-31 | $3.64M 20-F · filed 2021-03-29 | |||
| 2017-12-31 | $4.13M 20-F · filed 2020-04-03 | |||
| 2016-12-31 | $3.23M 20-F · filed 2019-04-10 |